GCA
ABT icon

Genesee Capital Advisors’s Abbott ABT Stock Holding History

Genesee Capital Advisors’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$953K Buy
9,283
+10
+0.1% +$1.13K 0.4% 63
2025
Q4 		$1.16M Buy
9,273
+669
+8% +$85.2K 0.47% 52
2025
Q3 		$1.15M Buy
8,604
+37
+0.4% +$4.86K 0.5% 52
2025
Q2 		$1.17M Buy
8,567
+374
+5% +$49.3K 0.52% 50
2025
Q1 		$1.09M Sell
8,193
-337
-4% -$42.9K 0.54% 42
2024
Q4 		$965K Sell
8,530
-45
-0.5% -$5.2K 0.45% 51
2024
Q3 		$978K Sell
8,575
-105
-1% -$11.5K 0.47% 49
2024
Q2 		$902K Sell
8,680
-252
-3% -$26.7K 0.44% 49
2024
Q1 		$1.02M Sell
8,932
-19
-0.2% -$2.18K 0.56% 44
2023
Q4 		$985K Sell
8,951
-5,026
-36% -$502K 0.61% 42
2023
Q3 		$1.35M Sell
13,977
-553
-4% -$58.1K 0.97% 31
2023
Q2 		$1.58M Sell
14,530
-273
-2% -$29.1K 1.08% 25
2023
Q1 		$1.5M Buy
14,803
+16
+0.1% +$1.69K 1.06% 22
2022
Q4 		$1.62M Sell
14,787
-1,020
-6% -$106K 1.21% 21
2022
Q3 		$1.53M Sell
15,807
-261
-2% -$27.8K 1.16% 19
2022
Q2 		$1.75M Sell
16,068
-2,437
-13% -$277K 1.22% 19
2022
Q1 		$2.19M Sell
18,505
-473
-2% -$58.6K 1.14% 24
2021
Q4 		$2.67M Buy
18,978
+209
+1% +$26.8K 1.28% 22
2021
Q3 		$2.22M Buy
+18,769
New +$2.31M 1.09% 27
2021
Q2 		– Sell
-19,089
Closed -$2.29M – 45
2021
Q1 		$2.29M Sell
19,089
-482
-2% -$57.1K 1.36% 19
2020
Q4 		$2.14M Buy
19,571
+281
+1% +$30.5K 1.4% 26
2020
Q3 		$2.1M Sell
19,290
-383
-2% -$38.9K 1.73% 13
2020
Q2 		$1.8M Sell
19,673
-3,017
-13% -$273K 1.67% 17
2020
Q1 		$1.79M Sell
22,690
-4,541
-17% -$379K 1.71% 13
2019
Q4 		$2.37M Sell
27,231
-416
-2% -$34.8K 2.01% 13
2019
Q3 		$2.31M Buy
27,647
+305
+1% +$25.9K 2.14% 12
2019
Q2 		$2.3M Sell
27,342
-864
-3% -$68K 2.32% 10
2019
Q1 		$2.25M Buy
28,206
+1,827
+7% +$136K 2.71% 9
2018
Q4 		$1.91M Buy
+26,379
New +$1.85M 3.12% 6

Other funds holding ABT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Genesee Capital Advisors's ABT Position: Q1 2026 in Review

Genesee Capital Advisors increased its Abbott (ABT) stake by 0.11% in Q1 2026, buying an estimated $1.13K and bringing the position to 9,283 shares worth $953K. The position accounts for 0.4% of the portfolio, ranked #63.

Genesee Capital Advisors first reported a position in ABT in Q4 2018 and has held it in 29 quarters since. The position peaked at $2.67M in Q4 2021. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Genesee Capital Advisors held 9,283 shares of Abbott worth $953K as of Q1 2026.
  • Genesee Capital Advisors bought 10 Abbott shares in Q1 2026, an estimated $1.13K.
  • Abbott made up 0.4% of Genesee Capital Advisors's portfolio in Q1 2026, its #63 holding.
  • Genesee Capital Advisors first reported a position in Abbott in Q4 2018 and has held it in 29 quarters since.
  • Genesee Capital Advisors's Abbott position peaked at $2.67M in Q4 2021.
  • 3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Genesee Capital Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.